| 2.26 0.05 (2.26%) | 07-15 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 2.93 | 1-year : | 3.16 |
| Resists | First : | 2.51 | Second : | 2.71 |
| Pivot price | 2.31 |
|||
| Supports | First : | 2.19 | Second : | 1.82 |
| MAs | MA(5) : | 2.23 |
MA(20) : | 2.37 |
| MA(100) : | 2.6 |
MA(250) : | 3.08 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 10.2 |
D(3) : | 6.1 |
| RSI | RSI(14): 34.2 |
|||
| 52-week | High : | 4.96 | Low : | 2.19 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NAII ] has closed above bottom band by 31.4%. Bollinger Bands are 15.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.3 - 2.31 | 2.31 - 2.32 |
| Low: | 2.19 - 2.21 | 2.21 - 2.22 |
| Close: | 2.24 - 2.26 | 2.26 - 2.28 |
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
Wed, 15 Jul 2026
Top 3 Risk Off Stocks That May Rocket Higher In Q3 - Benzinga
Sun, 21 Jun 2026
Natural Alternatives International (NAII) Rallies 6.37%: Breakout Potential or Short-Term Bounce? - Mid Cap Momentum - DonanımHaber
Fri, 19 Jun 2026
Natural Alternatives International Inc. (NAII) Surges Over 6% as Shares Test Key Resistance Level - Butterfly Setup - DonanımHaber
Thu, 04 Jun 2026
Natural Alternatives International Inc. (NAII) Q2 2024 Earnings: A Challenging Quarter with Reported Loss per Share - dars.gov.et
Mon, 01 Jun 2026
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure - Yahoo Finance
Mon, 25 May 2026
Legacy Corporate Lending Closes $31MM Asset-Based Revolver to Natural Alternatives - ABF Journal
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 6 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 21.6 (%) |
| Held by Institutions | 34.9 (%) |
| Shares Short | 7 (K) |
| Shares Short P.Month | 4 (K) |
| EPS | -2.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.34 |
| Profit Margin | -10.2 % |
| Operating Margin | -11.4 % |
| Return on Assets (ttm) | -2.5 % |
| Return on Equity (ttm) | -20.6 % |
| Qtrly Rev. Growth | 23.2 % |
| Gross Profit (p.s.) | 1.72 |
| Sales Per Share | 22.59 |
| EBITDA (p.s.) | -0.23 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.95 |
| PEG Ratio | 5.4 |
| Price to Book value | 0.21 |
| Price to Sales | 0.1 |
| Price to Cash Flow | -3.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |